comprehensive -WSS

comprehensive

author：knowledge 2025-08-12 09:13:13 - browse：34

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： BIO to announce reorganization, senior leaders expected to depart

leisure time

WSS

In Memoriam: Notable people who died in 2023

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

The high cost of giving birth even with insurance

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Moonlake's readout produced a cash windfall. Risks remain

leisure time

comprehensive

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Primary care doctor shortage won't be solved by free med school tuition

Malaria cases in Florida and Texas: Here’s what you need to know

Continuity nursing helped my family in our darkest PICU moments

Trump demands the U.S. pay no more for drugs than other countries … again

How to save PrEP access — and even expand it

Heart attack and stroke risk calculators need revising

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Affirmative action in medical school literally saved lives

23andMe had bad news about my health. I wish a person had delivered it

entertainment

Brain technologies pose threats that are all too real, experts warn

AltruBio raises $225 million to develop ulcerative colitis drug

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Jerome Adams on the need for new antivirals for Covid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

focus

hotspot

leisure time

explore